Researchers reported that angiotensin-converting enzyme (ACE) inhibitors can improve coronary flow velocity reserve (CFVR) in patients with type 2 diabetes.

Even a short treatment period can have an effect on neuropathic symptoms.

Both active and passive smoking increase the risk of developing glucose intolerance, according to the results of a prospective cohort study.

Postprandial blood glucose is better than fasting blood glucose in predicting cardiovascular events in patients with type 2 diabetes.

A single daily dose of 2000 mg. was shown to be effective in decreasing fasting plasma glucose levels.

Long-term, biannual dietary intervention reduces risk for insulin resistance in children, according to the results of a randomized study.

In a study of healthy volunteers, gastric electrical stimulation (GES) using endoscopically placed electrodes reduced the subjects’ food and water intake and seemed to delay gastric empty.

Between 2002 to 2005, the use of agents to prevent or treat type 2 diabetes among US children, 5 to 19 years of age, increased from about 0.3 to 0.6 per 1000, which could have “enormous implications” for long-term healthcare needs and expenses, new research shows.

Candesartan reduces inflammation, increases plasma adiponectin and improves insulin sensitivity in patients with hypertension, a new study shows.

A major international study has shown that many people with type-2 diabetes are not achieving optimal blood sugar control despite the availability of effective treatments – a shortfall that may underscore the benefits of dietary approaches.